Type 2 diabetes drug cost-effective for cardiovascular and kidney benefits, finds Australian study


Medication that helps reduce a person’s risk of developing cardiovascular and kidney disease is a cost-effective option to treat Australia’s entire population of people with type 2 diabetes, a new study has found.

Clinician nudge ups initiation of statin prescribing in primary care

Previous article

Early life experiences can affect gene activity more than half a lifetime later

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations